Use pSivida Corporation management performance together with your assets to enhance returns of your portfolios as well as to check it against diversification policy that fits your risk preferences.
pSivida Management Effectiveness
The company has return on total asset (ROA) of (15.38) % which means that it has lost $15.38 on every $1 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (86.45) % meaning that it created substantial loss on money invested by shareholders.
pSivida Profit Margins
The company has Profit Margin (PM) of (129.26) % which may suggest that it does not properly executes on its current pricing strategies or is unable to controls all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (131.26) % which suggests for every dolor of sales it generated a net operating loss of -1.31.
Leonard Ross Principal Financial Officer, Principal Accounting Officer and VP of Fin.
BA, Esq VP of Corporate Affairs, General Counsel and Secretary
pSivida Corporation Workforce
pSivida Corporation is rated below average in number of employees category among related companies. The total workforce of Drug Delivery industry is at this time estimated at about 24,247. pSivida adds roughly 26.0 in number of employees claiming only tiny portion of equities under Drug Delivery industry.
Dr. Paul Ashton is President, Chief Executive Officer, Director of pSivida Corporation Dr. Ashton has served as President and Chief Executive Officer since January 2009 and was previously Managing Director from January 2...
Dr. David J. Mazzo, Ph.D., is Chairman of the Board of pSivida Corporation Dr. Mazzo is President and Chief Executive Officer, and a director, of Regado Biosciences, Inc., a company pioneering the development of antithro...
pSivida employes about 26 people. The company is managed by 12 executives with total tenure of roughly 29 years, averanging almost 2.0 years of service per executive having 2.0 employee per reported executive.
Return on pSivida Manpower
Revenue Per Employee
251.5 K
Revenue Per Executive
545 K
Net Loss Per Employee
873.5 K
Net Loss Per Executive
1.9 M
Working Capital Per Employee
588.7 K
Working Capital Per Executive
1.3 M
pSivida Earnings Per Share
According to company disclosure pSivida Corporation has Earnings Per Share of -1.09 times. This is 202.83% lower than that of Healthcare sector, and 309.62% lower than that of Drug Delivery industry, The Earnings Per Share for all stocks is 173.65% higher than the company.
Earnings per Share is one of the most important measures of current share price of a firm, and is used by investors to determine company overall profitability especially when it is compared to EPS of similar companies.
USA 
Equity Search
Advanced Search
Market Screener
Adviser Directory
Suggest Portfolio
Backtest Watchlist
Analyze Correlations
View Transactions
Check Volatility
Import Equities
Summary
Fundamentals
Technicals
Performance
Valuation
Volatility
History
News
Management
Discussion
